Package 59651-422-01

Brand: cevimeline hydrochloride

Generic: cevimeline hydrochloride
NDC Package

Package Facts

Identity

Package NDC 59651-422-01
Digits Only 5965142201
Product NDC 59651-422
Description

100 CAPSULE in 1 BOTTLE (59651-422-01)

Marketing

Marketing Status
Marketed Since 2023-04-18
Brand cevimeline hydrochloride
Generic cevimeline hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d08d8aa5-76a4-417a-a308-7d195865522f", "openfda": {"unii": ["P81Q6V85NP"], "rxcui": ["309140"], "spl_set_id": ["d08d8aa5-76a4-417a-a308-7d195865522f"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (59651-422-01)", "package_ndc": "59651-422-01", "marketing_start_date": "20230418"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (59651-422-05)", "package_ndc": "59651-422-05", "marketing_start_date": "20230418"}], "brand_name": "Cevimeline Hydrochloride", "product_id": "59651-422_d08d8aa5-76a4-417a-a308-7d195865522f", "dosage_form": "CAPSULE", "pharm_class": ["Cholinergic Muscarinic Agonists [MoA]", "Cholinergic Receptor Agonist [EPC]"], "product_ndc": "59651-422", "generic_name": "Cevimeline Hydrochloride", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cevimeline Hydrochloride", "active_ingredients": [{"name": "CEVIMELINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA215056", "marketing_category": "ANDA", "marketing_start_date": "20230418", "listing_expiration_date": "20261231"}